South America Pharmaceutical Excipients Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. South America Pharmaceutical Excipients Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. South America Pharmaceutical Excipients Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Growing demand for drug formulations
5.1.2 Rise in biologic and generic drugs

5.2 Market Opportunities

5.2.1 Expansion in pharmaceutical excipients market
5.2.2 Growth in oral solid dosage forms

5.3 Future Trends

5.3.1 Growth in biopharmaceutical excipients
5.3.2 Increasing demand for customized drug delivery systems

5.4 Impact of Drivers and Restraints

6. South America Pharmaceutical Excipients Market Regional Analysis

6.1 South America Pharmaceutical Excipients Market Overview

6.2 South America Pharmaceutical Excipients Market Revenue 2020-2028 (US$ Million)

6.3 South America Pharmaceutical Excipients Market Forecast Analysis

7. South America Pharmaceutical Excipients Market Analysis – by Type

7.1 Bioresorbable Polymers

7.1.1 Overview
7.1.2 Bioresorbable Polymers: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Lipids and Liposome-Based Formulation

7.2.1 Overview
7.2.2 Lipids and Liposome-Based Formulation: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Oleochemicals

7.3.1 Overview
7.3.2 Oleochemicals: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Sugars

7.4.1 Overview
7.4.2 Sugars: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Cellulose

7.5.1 Overview
7.5.2 Cellulose: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)

7.6 Starches

7.6.1 Overview
7.6.2 Starches: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)

7.7 Petrochemicals

7.7.1 Overview
7.7.2 Petrochemicals: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)

7.8 Plant Proteins and Polyols and Cyclodextrins

7.8.1 Overview
7.8.2 Plant Proteins and Polyols and Cyclodextrins: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)

7.9 Inorganic Chemicals

7.9.1 Overview
7.9.2 Inorganic Chemicals : South America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)

7.10

7.10.1 Overview
7.10.2 : South America Pharmaceutical Excipients Market – Revenue and Forecast to 2031 (US$ Million)

8. South America Pharmaceutical Excipients Market Analysis – by Clinical Indication

8.1 Cancer

8.1.1 Overview
8.1.2 Cancer: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Metabolic

8.2.1 Overview
8.2.2 Metabolic: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Infectious Diseases

8.3.1 Overview
8.3.2 Infectious Diseases: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Dental

8.4.1 Overview
8.4.2 Dental: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Ophthalmic

8.5.1 Overview
8.5.2 Ophthalmic: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Gene Therapies

8.6.1 Overview
8.6.2 Gene Therapies: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

9. South America Pharmaceutical Excipients Market Analysis – by Functionality

9.1 Coloring Agent and Coating Agent

9.1.1 Overview
9.1.2 Gene Therapies: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Sweetener and Flavoring Agents

9.2.1 Overview
9.2.2 Gene Therapies: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Suspending and Viscosity Agents

9.3.1 Overview
9.3.2 Gene Therapies: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Preservative and Controlled-Release

9.4.1 Overview
9.4.2 Gene Therapies: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Antioxidant and Oil

9.5.1 Overview
9.5.2 Gene Therapies: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Tablet Filler and Diluents

9.6.1 Overview
9.6.2 Gene Therapies: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

9.7 Binders and Compression Aids and Granulating Agents

9.7.1 Overview
9.7.2 Gene Therapies: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

10. South America Pharmaceutical Excipients Market – South and Central America Analysis

10.1 South and Central America

10.1.1 South America Pharmaceutical Excipients Market Breakdown, by Key Country, 2023 and 2028 (%)
10.1.1.1 South America Pharmaceutical Excipients Market – Revenue and Forecast Analysis – by Country
10.1.1.1 Brazil: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Brazil: South America Pharmaceutical Excipients Market Breakdown, by Type
10.1.1.1.2 Brazil: South America Pharmaceutical Excipients Market Breakdown, by Clinical Indication
10.1.1.1.3 Brazil: South America Pharmaceutical Excipients Market Breakdown, by Functionality

10.1.1.2 Argentina: South America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Argentina: South America Pharmaceutical Excipients Market Breakdown, by Type
10.1.1.2.2 Argentina: South America Pharmaceutical Excipients Market Breakdown, by Clinical Indication
10.1.1.2.3 Argentina: South America Pharmaceutical Excipients Market Breakdown, by Functionality

10.1.1.3 Rest of South and Central America : South America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Rest of South and Central America : South America Pharmaceutical Excipients Market Breakdown, by Type
10.1.1.3.2 Rest of South and Central America : South America Pharmaceutical Excipients Market Breakdown, by Clinical Indication
10.1.1.3.3 Rest of South and Central America : South America Pharmaceutical Excipients Market Breakdown, by Functionality

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. South America Pharmaceutical Excipients Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Archer-Daniels-Midland Co

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 AshLand Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Avantor Inc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 BASF SE

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Evonik Industries AG

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 JRS PHARMA GmbH & Co. KG

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 MEGGLE GmbH & Co KG

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Roquette Freres SA

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 The Dow Chemical Co

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 The Lubrizol Corp

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights